In dopaminergic neurons derived from PD patients with LRRK2 mutations, GCase activity is diminished, and inhibition of the kinase activity of LRRK2 leads to increased GCase activity, with the LRRK2 substrate Rab10 as a key mediator in the regulation of this process [95]. The gene discussed is LRRK2; the disease is Parkinson disease.